Skip to main content

Table 2 Outcome of TACE before and after propensity score matching analysis in UICC T3 HCC patients

From: Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study

Variables Before PSM After PSM
TACE (n = 899) TACE (n = 244)
Procedures (mean ± SD) 1.8 ± 1.2 1.9 ± 1.2
1 procedure 457 (50.8) 118(48.3)
2–3 procedures 365 (40.6) 103(42.2)
more than 3 procedures 77 (8.6) 23(9.4)
Best tumor response, n (%)   
CR 18 (2.0) 6 (2.5)
PR 203 (22.6) 56 (23.0)
SD 259 (28.8) 73 (29.9)
DCR (CR + PR + SD) 480 (53.4) 135 (55.3)
Median TTP (95%CI) months 5.7(4.7–6.6) 7.7 (5.7–9.8)
Cases of PD, n (%) 419 (46.6) 109 (44.7)
Patterns of PD   
Enlarged or new lesion (n, %) 186 (20.7) 49 (20.1)
Metastasis or vessel invasion (n, %) 233 (25.9) 60 (24.6)
Treatment after TACE   
Heat ablation (n, %) 135 (15.0) 43 (17.6)
Resection (n, %) 93 (10.3) 27 (11.1)
Sorafenib (n, %) 86 (9.6) 21 (8.6)
  1. Abbreviations: UICC the Union for International Cancer Control, TACE transarterial chemoembolization, CR complete response, PR partial response, SD stable disease, DCR disease control rate, TTP time to progression, CI confidence interval, PSM propensity score matching